Dosage and utilization of dexamethasone in the management of COVID-19: A critical review

doi:10.5501/wjv.v13.i3.95709

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2328)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

HTML

1116

Figures (1-5)

214

Tables (1-1)

260

Sum=1667

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

153

Download

200

Sum=353

Publishing Process of This Article

Item

Count

Browse

Download

147

Sum=233

Sep 25, 2024 (publication date) through Mar 16, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Virol. Sep 25, 2024; 13(3): 95709
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.95709

Full Size Figure Download Figure

Figure 2 Pooled odds ratio for 28-day mortality rates.

Citation: Sethi I, Shaikh A, Sethi M, Chohan HK, Younus S, Khan SA, Surani S. Dosage and utilization of dexamethasone in the management of COVID-19: A critical review. World J Virol 2024; 13(3): 95709
URL: https://www.wjgnet.com/2220-3249/full/v13/i3/95709.htm
DOI: https://dx.doi.org/10.5501/wjv.v13.i3.95709